Oküler Hastalıkların Tedavisi İçin Hidrojel Bazlı İlaç Taşıyıcı Sistemler
Referanslar
Polat, HK, Kurt, N, Aytekin, E, et al. Novel Drug Delivery Systems to Improve the Treatment of Keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2022;38(6):376–395. doi: 10.1089/jop.2021.0127
Thrimawithana TR, Rupenthal ID, Räsch SS, et al. Drug delivery to the lens for the management of cataracts. Advanced drug delivery reviews. 2018;126:185-94.doi: 10.1016/j.addr.2018.03.009
Al-Kinani AA, Zidan G, Elsaid N, et al. Ophthalmic gels: Past, present and future. Advanced Drug Delivery Reviews. 2018;126:113-26.doi: 10.1016/j.addr.2017.12.017
Ilochonwu BC, Urtti A, Hennink WE, et al. Intravitreal hydrogels for sustained release of therapeutic proteins. Journal of Controlled Release. 2020;326:419-41.doi: 10.1016/j.jconrel.2020.07.031
Grassiri B, Zambito Y, Bernkop-Schnürch A. Strategies to prolong the residence time of drug delivery systems on ocular surface. Advances in colloid and interface science. 2021;288:102342.doi: 10.1016/j.cis.2020.102342
Arranz-Romera A, Esteban-Perez S, Garcia-Herranz D, et al. Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases. Drug Discovery Today. 2019;24(8):1644-53.doi: 10.1016/j.drudis.2019.03.022
Phadatare SP, Momin M, Nighojkar P, et al. A comprehensive review on dry eye disease: diagnosis, medical management, recent developments, and future challenges. Advances in Pharmaceutics. 2015;2015.doi: 10.1155/2015/704946
Baudouin C, Irkeç M, Messmer EM, et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta ophthalmologica. 2018;96(2):111-9.doi: 10.1111/aos.13436
Singh M, Bharadwaj S, Lee KE, et al. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery. Journal of Controlled Release. 2020;328:895-916.doi: 10.1016/j.jconrel.2020.10.025
H. KP. In Situ Gels Triggered by Temperature for Ocular Delivery of Dexamethasone and Dexamethasone/ SBE-β-CD Complex. Journal of research in pharmacy. 2022;26(4):873-83.doi: 10.29228/jrp.186
Tham Y-C, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-90.doi: 10.1016/j.ophtha.2014.05.013
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. Jama. 2014;311(18):1901-11.doi: 10.1001/jama.2014.3192
Konstas AG, Schmetterer L, Costa VP, et al. Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety. 2020;19(11):1445-60.doi: 10.1080/14740338.2020.1826928
Burkholder BM, Jabs DA. Uveitis for the non-ophthalmologist. Bmj. 2021;372.doi: 10.1136/bmj.m4979
Iyer S, Radwan AE, Hafezi-Moghadam A, et al. Long-acting intraocular Delivery strategies for biological therapy of age-related macular degeneration. Journal of controlled release. 2019;296:140-9.doi: 10.1016/j.jconrel.2019.01.007
LaMattina KC, Goldstein DA. Adalimumab for the treatment of uveitis. Expert Review of Clinical Immunology. 2017;13(3):181-8. doi: 10.1080/1744666X.2017.1288097
Triantafylla M, Massa HF, Dardabounis D, et al. Ranibizumab for the treatment of degenerative ocular conditions. Clinical ophthalmology (Auckland, NZ). 2014;8:1187.doi: 10.2147/OPTH.S40350
Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nature reviews Drug discovery. 2012;11(7):541-59.doi: 10.1038/nrd3745
Lau CML, Yu Y, Jahanmir G, et al. Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges. Advanced drug delivery reviews. 2018;126:145-61.doi: 10.1016/j.addr.2018.03.013
Dubald M, Bourgeois S, Andrieu V, et al. Ophthalmic drug delivery systems for antibiotherapy—a review. Pharmaceutics. 2018;10(1):10.doi: 10.3390/pharmaceutics10010010
Sánchez-López E, Espina M, Doktorovova S, et al. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part II-Ocular drug-loaded lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 2017;110:58-69.doi: 10.1016/j.ejpb.2016.10.013
Han Q, Wang Y, Li X, et al. Effects of bevacizumab loaded PEG-PCL-PEG hydrogel intracameral application on intraocular pressure after glaucoma filtration surgery. Journal of Materials Science: Materials in Medicine. 2015;26(8):1-9.doi: 10.1007/s10856-015-5556-6
Xu J, Ge Y, Bu R, et al. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma. Journal of Controlled Release. 2019;305:18-28.doi: 10.1016/j.jconrel.2019.05.025
Polat Hk, Sedat Ü. Development Of In Situ Gel Formulation Containing Bisphosphonate-Loaded Plga Microspheres For Bone Regeneration In Maxillofacial Surgery Applications; Formulations, In Vitro Characterization And Release Kinetic Studies. Journal of Faculty of Pharmacy of Ankara University. 2022;46(3):993-1008.doi: 10.33483/jfpau.1149890
Song Y, Nagai N, Saijo S, et al. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery. Materials Science and Engineering: C. 2018;88:1-12.doi: 10.1016/j.msec.2018.02.022
Vermonden T, Censi R, Hennink WE. Hydrogels for protein delivery. Chemical reviews. 2012;112(5):2853-88.doi: 10.1021/cr200157d
Wasupalli GK, Verma D. Injectable and thermosensitive nanofibrous hydrogel for bone tissue engineering. Materials Science and Engineering: C. 2020;107:110343.doi: 10.1016/j.msec.2019.110343
Chen Z, Yang M, Wang Q, et al. Hydrogel eye drops as a non-invasive drug carrier for topical enhanced Adalimumab permeation and highly efficient uveitis treatment. Carbohyd Polym. 2021;253:117216.
Iohara D, Okubo M, Anraku M, et al. Hydrophobically modified polymer/α-cyclodextrin thermoresponsive hydrogels for use in ocular drug delivery. Molecular pharmaceutics. 2017;14(8):2740-8.doi: 10.1016/j.carbpol.2020.117216
Fang G, Yang X, Wang Q, et al. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Materials Science and Engineering: C. 2021;127:112212.doi: 10.1016/j.msec.2021.112212
Nguyen DD, Lai J-Y. Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment. Polymer Chemistry. 2020;11(44):6988-7008.doi: 10.1039/D0PY00919A
Sun J, Zhou Z. A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation. Drug design, development and therapy. 2018;12:383.doi: 10.2147/DDDT.S153405
Ge Y, Zhang A, Sun R, et al. Penetratin-modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration. Expert Opinion on Drug Delivery. 2020;17(4):603-19.doi: 10.1080/17425247.2020.1735348
Iglesias N, Galbis E, Romero-Azogil L, et al. In-depth study into polymeric materials in low-density gastroretentive formulations. Pharmaceutics. 2020;12(7):636.doi: 10.3390/pharmaceutics12070636
Kouchak M, Mahmoodzadeh M, Farrahi F. Designing of a pH-triggered Carbopol®/HPMC in situ gel for ocular delivery of dorzolamide HCl: in vitro, in vivo, and ex vivo evaluation. AAPS PharmSciTech. 2019;20(5):1-8.doi: 10.1208/s12249-019-1431-y
Zamboulis A, Nanaki S, Michailidou G, et al. Chitosan and its derivatives for ocular delivery formulations: recent advances and developments. Polymers. 2020;12(7):1519.doi: 10.3390/polym12071519
Ali Y, and Lehmussaari, K. Industrial perspective in ocular drug delivery. Advanced drug delivery reviews. 2006;58:1258–68.doi: 10.1016/j.addr.2006.07.022
Horvát G, Gyarmati B, Berkó S, et al. Thiolated poly (aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system. European Journal of Pharmaceutical Sciences. 2015;67:1-11.doi: 10.1016/j.ejps.2014.10.013
Summonte S, Racaniello GF, Lopedota A, et al. Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms. Journal of Controlled Release. 2021;330:470-82.doi 10.1016/j.jconrel.2020.12.037
Maulvi FA, Shaikh AA, Lakdawala DH, et al. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation. Acta biomaterialia. 2017;53:211-21.doi: 10.1016/j.actbio.2017.01.063
Torres-Luna C, Fan X, Domszy R, et al. Hydrogel-based ocular drug delivery systems for hydrophobic drugs. European Journal of Pharmaceutical Sciences. 2020;154:105503.doi 10.1016/j.ejps.2020.105503
Pimenta A, Ascenso J, Fernandes J, et al. Controlled drug release from hydrogels for contact lenses: Drug partitioning and diffusion. International Journal of Pharmaceutics. 2016;515(1-2):467-75.doi: 10.1016/j.ijpharm.2016.10.047
Xu J, Xue Y, Hu G, et al. A comprehensive review on contact lens for ophthalmic drug delivery. Journal of Controlled Release. 2018;281:97-118.doi: 10.1016/j.jconrel.2018.05.020
Chatterjee S, Upadhyay P, Mishra M, et al. Advances in chemistry and composition of soft materials for drug releasing contact lenses. RSC advances. 2020;10(60):36751-77.doi: 10.1039/D0RA06681H
Hsu K-H, Carbia BE, Plummer C, et al. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2015;94:312-21.doi: 10.1016/j.ejpb.2015.06.001
Kim J, Peng C-C, Chauhan A. Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E. Journal of Controlled Release. 2010;148(1):110-6.doi: 10.1016/j.jconrel.2010.07.119
Dixon P, Ghosh T, Mondal K, et al. Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation. Drug Delivery and Translational Research. 2018;8(5):1114-26.doi: 10.1007/s13346-018-0541-5
Peng C-C, Burke MT, Chauhan A. Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses. Langmuir. 2012;28(2):1478-87.doi: 10.1021/la203606z
Xu J, Li X, Sun F. Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release. Acta biomaterialia. 2010;6(2):486-93.doi: 10.1016/j.actbio.2009.07.021
Glisoni RJ, García-Fernández MJ, Pino M, et al. β-Cyclodextrin hydrogels for the ocular release of antibacterial thiosemicarbazones. Carbohydrate polymers. 2013;93(2):449-57.doi: 10.1016/j.carbpol.2012.12.033
dos Santos J-FR, Couceiro R, Concheiro A, et al. Poly (hydroxyethyl methacrylate-co-methacrylated-β-cyclodextrin) hydrogels: Synthesis, cytocompatibility, mechanical properties and drug loading/release properties. Acta Biomaterialia. 2008;4(3):745-55.doi: 10.1016/j.actbio.2007.12.008
Reimondez-Troitiño S, Csaba N, Alonso M, et al. Nanotherapies for the treatment of ocular diseases. European Journal of Pharmaceutics and Biopharmaceutics. 2015;95:279-93.doi: 10.1016/j.ejpb.2015.02.019
Garcia-Millan E, Quintans-Carballo M, Otero-Espinar FJ. Improved release of triamcinolone acetonide from medicated soft contact lenses loaded with drug nanosuspensions. International journal of pharmaceutics. 2017;525(1):226-36.doi: 10.1016/j.ijpharm.2017.03.082
ElShaer A, Mustafa S, Kasar M, et al. Nanoparticle-laden contact lens for controlled ocular delivery of prednisolone: Formulation optimization using statistical experimental design. Pharmaceutics. 2016;8(2):14.doi: 10.3390/pharmaceutics8020014
Hiratani H, Fujiwara A, Tamiya Y, et al. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials. 2005;26(11):1293-8.doi: 10.1016/j.biomaterials.2004.04.030
Alvarez-Lorenzo C, Yanez F, Barreiro-Iglesias R, et al. Imprinted soft contact lenses as norfloxacin delivery systems. Journal of Controlled Release. 2006;113(3):236-44.doi: 10.1016/j.jconrel.2006.05.003
Tieppo A, White C, Paine A, et al. Sustained in vivo release from imprinted therapeutic contact lenses. Journal of controlled release. 2012;157(3):391-7.doi: 10.1016/j.jconrel.2011.09.087
Rzhevskiy AS, Singh TRR, Donnelly RF, et al. Microneedles as the technique of drug delivery enhancement in diverse organs and tissues. Journal of controlled release. 2018;270:184-202.doi: 10.1016/j.jconrel.2017.11.048
Turner JG, White LR, Estrela P, et al. Hydrogel‐Forming Microneedles: Current Advancements and Future Trends. Macromolecular Bioscience. 2021;21(2):2000307.doi: 10.1002/mabi.202000307
Amer M, Chen RK. Self‐Adhesive Microneedles with Interlocking Features for Sustained Ocular Drug Delivery. Macromolecular Bioscience. 2020;20(6):2000089.doi: 10.1002/mabi.202000089
Spierer O, O'Brien TP. Endothelial keratoplasty combined with cataract surgery or alone using polyethylene glycol hydrogel sealant for closure of corneal incisions. Journal of Cataract & Refractive Surgery. 2015;41(3):492-6.doi: 10.1016/j.jcrs.2015.02.002
Chowhan A, Giri TK. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route. International journal of biological macromolecules. 2020;150:559-72.doi: 10.1016/j.ijbiomac.2020.02.097
Nagaraj R, Bijukumar DR, Mathew B, et al. A review on recent advancements in ophthalmology devices: Currently in market and under clinical trials. Journal of Drug Delivery Science and Technology. 2019;52:334-45.doi: 10.1016/j.jddst.2019.04.038
